Chemours Co Stock Pattern Recognition Breakaway
| CC Stock | USD 17.57 -0.13 -0.73% |
| Symbol |
Recognition |
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. Chemours breakaway pattern warns about a short-term trend reversal.
Chemours Technical Analysis Modules
Most technical analysis of Chemours help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Chemours from various momentum indicators to cycle indicators. When you analyze Chemours charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware. Chemours operates under Specialty Chemicals classification in the United States and is traded on New York Stock Exchange. It employs 6400 people. A high-level view of Chemours emphasizes earnings durability, balance-sheet flexibility, and competitive positioning. Current metrics include P/E of 25.49, P/B of 10.63, profit margin of -6.65%. Chemours has a market cap of 2.66 B, P/E of 25.49, ROE of -93.8%.
Methodology
Unless otherwise specified, financial data for Chemours Co is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Chemours (USA Stocks:CC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR. Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Chemours Co is covered by 9 analysts. 4 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Citigroup, HSBC Global Research, Stifel, Wells Fargo Securities, UBS Investment Research, RBC Capital Markets, Bank of America Securities, J.P. Morgan, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardChemours Implied Volatility | 1.96 |
Chemours' implied volatility exposes the market's sentiment of Chemours Co stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Chemours' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Chemours stock will not fluctuate a lot when Chemours' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Chemours in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Chemours' short interest history, or implied volatility extrapolated from Chemours options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Corona Opportunity Invested few shares | |
 | Hedge Favorites Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Adviser Favorites Invested few shares | |
 | Momentum Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | Investor Favorites Invested few shares | |
 | ESG Investing Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Video Games Invested few shares |
More Resources for Chemours Stock Analysis
Chemours has a market cap of 2.66 B, operating margin of 2.03%, ROE of -93.8%. Use Trending Equities to explore allocation context. This includes a position in Chemours Co across the allocation. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Analysis related to Chemours should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Quarterly Earnings Growth -0.65 | Dividend Share 0.513 | Earnings Share -2.57 | Revenue Per Share | Quarterly Revenue Growth -0.02 |
The market value of Chemours is measured differently than book value, which reflects Chemours accounting equity. Chemours' market capitalization is 2.66 B. With a P/B ratio of 10.63, the market values Chemours well above its book equity. Enterprise value stands at 6.38 B. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Chemours' intrinsic value and market price are different measures derived from different inputs. For Chemours, key inputs include a P/E ratio of 25.49, a P/B ratio of 10.63, a profit margin of -6.65%, and ROE of -93.8%. Trading price represents the transaction level agreed by market participants.